Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR2 | O95665 | 5/20 | 0.53 |
| ▸ | NTSR1 | P30989 | 4/20 | 0.53 |
| ▸ | REN | P00797 | 11/20 | 0.52 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.50 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.50 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.50 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.49 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30438112 | 0.92 | NTSR2 (0.53) | NTSR2NTSR1RENSORT1 | |
| SCHEMBL29433159 | 0.89 | KDM1A (0.56) | MAPK8MAPK9MAPK10CALCRL | |
| SCHEMBL29779795 | 0.86 | NTSR1 (0.65) | NTSR2NTSR1SORT1 | |
| SCHEMBL29357733 | 0.85 | REN (0.57) | NTSR2NTSR1RENSORT1 | |
| SCHEMBL29433160 | 0.85 | KDM1A (0.53) | — | |
| SCHEMBL30262063 | 0.85 | VIPR2 (0.54) | CALCRL | |
| SCHEMBL29612189 | 0.84 | KDM1A (0.55) | NTSR2NTSR1REN | |
| SCHEMBL31124659 | 0.84 | NTSR2 (0.56) | NTSR2NTSR1RENSORT1 | |
| SCHEMBL30750436 | 0.83 | NTSR2 (0.60) | NTSR2NTSR1RENSORT1 | |
| SCHEMBL29608362 | 0.83 | REN (0.45) | RENCALCRL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109071622-B | Peptides with anticancer activity | IDP研发制药有限公司(ES) | 2023-01-13 | — | — | CN | disclosed |
| EP-4039698-A1 | PEPTIDES WITH ANTI-CANCER ACTIVITY | IDP Discovery Pharma, S.L. (ES) | 2022-08-10 | — | — | EP | disclosed |